The Discounted Cash Flow (DCF) valuation of Jazz Pharmaceuticals PLC (JAZZ) is 210.04 USD. With the latest stock price at 111.60 USD, the upside of Jazz Pharmaceuticals PLC based on DCF is 88.2%.
Based on the latest price of 111.60 USD and our DCF valuation, Jazz Pharmaceuticals PLC (JAZZ) is a buy. buying JAZZ stocks now will result in a potential gain of 88.2%.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 8.0% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 107.40 - 750.66 | 210.04 |
| Upside | -3.8% - 572.6% | 88.2% |